§ 27-55-3 - Advisory panel on off-label uses of prescription drugs.
SECTION 27-55-3
§ 27-55-3 Advisory panel on off-label usesof prescription drugs. – The director of the department of health shall appoint an advisory panel ofseven (7) medical experts. The purpose of the advisory panel is to makerecommendations to the director regarding whether a particular off-label use ismedically appropriate, whenever a particular dispute about payment for thisoff-label use is referred to the director of the department of health. Partiesseeking to refer a dispute to the director shall do so in writing within thirty(30) days of the denial of coverage of the drug. The members of the panel shallinclude seven (7) licensed Rhode Island physicians, including: (1) a physicianappointed by a hospital and medical services corporation; (2) a physicianappointed by the Rhode Island Medical Society; (3) three (3) medicaloncologists appointed by the society of Rhode Island Clinical Oncologists; (4)a physician appointed by the Rhode Island Association of Health MaintenanceOrganizations from a member plan; and (5) a Rhode Island physician appointed bythe Health Insurance Association of America. The members of the advisory panelshall serve at the pleasure of the director of the department of health andshall receive no compensation for their service on this advisory panel.